InSights Hub

Showing 211 to 220 of 366 (Page 22)

What's Changed & Predictions Age-Related Macular Degeneration

Age-Related Macular Degeneration Guidelines – What’s Changed Since & Guidelines Prediction Series

As the leading cause of irreversible blindness in adults 60 years of age and older, age-related macular degeneration (AMD) is a prevalent eye condition marked by central vision loss that impacts nearly 20 million individuals in the US. Despite its prevalence, afflicting approximately 1 in every 8 individuals above 60 years of age, there are […]

Read More
Guidelines Spotlight - Stimulant Use Disorder

Stimulant Use Disorder – Guidelines Spotlight

The American Society of Addiction Medicine (ASAM) and the American Academy of Addiction Psychiatry (AAAP) collaborated to develop the Clinical Practice Guideline on the Management of Stimulant Use Disorder (referred to as the Guideline). It was published on November 8, 2023. The Guideline aims to provide evidence-based strategies and clinically informed standards of care for […]

Read More
Guidelines + Journal Rundown Pediatrics

Top Pediatric Articles July 2024 – Guidelines+ Journals

In this post, we will be taking a closer look at some of the most popular pediatric-related articles recently published across medical journals. Infant Deaths After Texas’ 2021 Ban on Abortion in Early Pregnancy Global Prevalence of Overweight and Obesity in Children and Adolescents: A Systematic Review and Meta-Analysis Screening Accuracy of BMI for Adiposity […]

Read More
ACOG Pregnancy & Postpartum Algorithms

New Pregnancy and Postpartum Algorithms Published by ACOG

The American College of Obstetricians and Gynecologists (ACOG) and the Centers for Disease Control and Prevention (CDC) have collaborated on a multiyear initiative entitled “Identifying and Managing Obstetric Emergencies in Nonobstetric Settings.” This initiative addresses pregnancy-related emergencies and complications such as cardiomyopathy, preeclampsia, eclampsia, and stroke, as well as mental health conditions that can pose […]

Read More

AGA’s Ulcerative Colitis Guideline is Now Open for Public Comment

The American Gastroenterological Association (AGA) has announced that their latest guideline, “The AGA Living Guideline: Pharmacological Management of Moderate-To-Severe Ulcerative Colitis,” is now open for public comment. This guideline, aimed at supporting practitioners in the pharmacological management of moderate-to-severe ulcerative colitis (UC), features 14 recommendations designed to guide therapy decisions with a patient-centered approach. Referred […]

Read More
Guidelines Side-By-Side Psoriatic Arthritis

Analyzing Guidelines for Psoriatic Arthritis (PsA) – Guidelines Side-By-Side

Psoriatic arthritis (PsA) is a chronic, immune-mediated inflammatory arthritis that occurs most commonly in some people with psoriasis, a skin condition characterized by red, scaly patches. Research suggests that approximately 20-30% of people with psoriasis also develop PsA, with the majority of patient’s presenting with skin-related disease that precedes the onset of arthritis symptomatology, though […]

Read More
Guidelines Spotlight - Vitamin D for the Prevention of Disease

Vitamin D for the Prevention of Disease – Guidelines Spotlight

The Endocrine Society unveiled its latest guideline, “Vitamin D for the Prevention of Disease,” on June 3rd, 2024. This evidence-based guideline aims to establish clinical guidelines for the use of vitamin D to lower the risk of disease in individuals without established indications for vitamin D treatment or 25(OH)D testing. Recognized for its vital role […]

Read More
Upcoming FDA Approvals & Decisions - July 2024

Upcoming FDA Decisions – July 2024

The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]

Read More